entertainment -WSS

entertainment

author：focus 2025-08-12 09:12:25 - browse：478

Bristol Myers Squibb sign — Courtesy Bristol Myers Squibb

Bristol Myers Squibb will pay $4.1 billion for RayzeBio, the companies said Tuesday, buying into the fast-growing field of using targeted doses of radiation to treat cancer.

RayzeBio, which raised about $350 million in a September initial public offering, is working in radiopharmaceuticals, which pair the tumor-killing power of radiation with the precision of targeted cancer therapies. The company is currently running a pivotal trial of its most advanced drug, RYZ101, in neuroendocrine cancer and has a pipeline of treatments for kidney, liver, and other cancers.

Bristol Myers will pay $62.50 in cash per share of RayzeBio, a roughly 115% premium to the company’s recent trading and more than triple the company’s IPO price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Celiac disease study examines precisely how gluten triggers injury

leisure time

WSS

Care demand spikes challenge UnitedHealth’s provider arm

Involuntary treatment for addiction doesn't work

How generative AI ratchets up security threats for health systems

Merck, Johnson & Johnson CEOs will testify on high drug prices

Philips to halt sales of sleep apnea machines in U.S.

Merck, Johnson & Johnson CEOs will testify on high drug prices

explore

entertainment

hotspot

At least 13 dead in Texas as scorching temps continue

J&J expands global access to TB drug amid advocacy campaign

Hepatitis C has a cure — but many Americans still lack access to it

Medicare Advantage insurers face 0.2% cut to 2025 payments

Activists slam private health insurers over coverage restrictions

Reconstructing family trees of blood cells may help predict disease

Trump demands the U.S. pay no more for drugs than other countries … again

How generative AI ratchets up security threats for health systems

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

hotspot

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

The new HIV moral panic

Celiac disease study examines precisely how gluten triggers injury

Boston competes with Raleigh

Argenx drug significantly slows progression of nerve disorder

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

hotspot

focus

leisure time

focus